These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 869646)

  • 1. Pancreatolithiasis and pancreatic carcinoma. Evaluation of pancreatic excretion test with 5,5-dimethyl-2,4-oxazolidinedione.
    Noda A; Kamiya N; Takayama T; Hayakawa T
    Arch Intern Med; 1977 Jun; 137(6):754-60. PubMed ID: 869646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic excretion of 5,5-dimethyl-2,4-oxazolidinedione in patients with chronic pancreatitis.
    Noda A; Hayakawa T; Aoki I; Horiguchi Y; Toda Y
    Am J Dig Dis; 1975 Nov; 20(11):1019-26. PubMed ID: 1199992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic excretion of 5, 5-dimethyl-2, 4-oxazolidinedione in normal subjects.
    Noda A; Hayakawa T; Nakajima S; Suzuki T; Toda Y
    Am J Dig Dis; 1975 Nov; 20(11):1011-8. PubMed ID: 1199991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic excretion test and barrier hypothesis in progression of chronic pancreatitis.
    Noda A; Hayakawa T; Horiguchi Y; Naruse S; Iinuma Y
    Am J Gastroenterol; 1978 Jun; 69(6):673-82. PubMed ID: 707463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic excretion of dimethadione and trimethadione by repeated oral administration of trimethadione in dogs.
    Noda A; Okumura I; Kato H; Ibuki E; Tamada M; Watanabe T
    Digestion; 1990; 46(1):19-26. PubMed ID: 2210093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of pancreatic excretion test with dimethadione and oral BT-PABA test in chronic pancreatitis.
    Noda A; Hayakawa T; Kondo T; Katada N; Kameya A
    Dig Dis Sci; 1983 Mar; 28(3):230-5. PubMed ID: 6600678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetic study of trimethadione and dimethadione for lysis of pancreatic stones.
    Noda A; Yamamoto K; Nakanishi Y
    Gastroenterol Jpn; 1986 Apr; 21(2):167-71. PubMed ID: 3710055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The excretion of dimethadione in pure pancreatic juice and bile in postoperative patients.
    Noda A; Hayakawa T; Mizuno R; Hamano H; Murase T; Shibata T
    Gastroenterol Jpn; 1984 Apr; 19(2):121-6. PubMed ID: 6735069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioselenium pancreozymin-secretin test as a clinical test for pancreatic exocrine function.
    Shichiri M; Etani N; Yoshida M; Harano Y; Hoshi M; Shigeta Y; Abe H
    Am J Dig Dis; 1975 May; 20(5):460-8. PubMed ID: 1130371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for estimation of hepatic drug-metabolizing capacity: determination of concentration of trimethadione and its metabolite in human serum.
    Kobayashi S; Tanaka E; Oguchi K; Yoshida T; Kuroiwa Y; Yasuhara H
    J Pharmacobiodyn; 1984 May; 7(5):329-35. PubMed ID: 6470930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with the 'Triple Test' in pancreatic disease.
    Thompson HH; Brown CL; Murray RS; Wingate DL; Ritchie HD
    Ann R Coll Surg Engl; 1983 May; 65(3):176-9. PubMed ID: 6859780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dimethadione derived from repeated oral administration of trimethadione on pancreatic secretion in dogs.
    Noda A; Okumura I; Ibuki E; Hotta S; Nomoto K; Miyamoto E; Takeuchi K; Watanabe T
    Gastroenterol Jpn; 1990 Oct; 25(5):613-8. PubMed ID: 2227252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotonic duodenography and secretin-CCK test in the diagnosis of pancreatic disease.
    Lukes PJ; Rolny P; Nilson AE; Gamklou R
    Acta Radiol Diagn (Stockh); 1981; 22(1):31-7. PubMed ID: 7257850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of pancreatic diseases: Biochemical tests].
    Toda Y; Noda A; Hayakawa T; Nakajima S; Suzuki T
    Nihon Rinsho; 1973 Mar; 31(3):519-26. PubMed ID: 4598378
    [No Abstract]   [Full Text] [Related]  

  • 15. Trimethadione metabolism in patients with normal liver and in patients with chronic liver disease.
    Tanaka E; Ishikawa A; Ono A; Okamura T; Misawa S
    J Pharmacobiodyn; 1987 Sep; 10(9):499-502. PubMed ID: 2830397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of the tests used in the diagnosis of pancreatic diseases].
    Lenti G; Emanuelli G
    Minerva Med; 1976 Nov; 67(55):3661-70. PubMed ID: 995311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parotid saliva test compared with pancreozymin-secretin test in diagnosis of pancreatic disorders.
    Kakizaki G; Saito T; Soeno T; Sasahara M; Oizumi T
    Tohoku J Exp Med; 1974 Nov; 114(3):241-5. PubMed ID: 4456685
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of secretin and cholecystokinin-pancreozymin on plasma CEA concentration in patients with pancreatic carcinoma and pancreatitis.
    Lindstedt G; Lundberg PA; Rolny P
    Cancer; 1979 Jun; 43(6):2465-70. PubMed ID: 455230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of allyl alcohol and bromobenzene on trimethadione metabolism in the rat.
    Tanaka E; Nakamura T; Misawa S; Yoshida T; Kuroiwa Y
    Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):137-51. PubMed ID: 6473897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical importance of the secretin-pancreozymin test in the diagnosis of chronic and neoplastic exocrine pancreatopathies].
    Taschieri AM; Pucci C; Scortecci V; Trivellini G
    Arch Ital Chir; 1967; 93(1):697-713. PubMed ID: 5621876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.